Investigation on the effect of age and gender variables on SARS-CoV-2 in persons applying to a hospital in İstanbul

Year 2024, Volume: 10 Issue: 4, 293 - 308, 30.11.2024

Devran Şener , Zeynep Kolören , Ülkü Karaman , Yeliz Kaşko Arıcı

https://doi.org/10.19127/mbsjohs.1486980

Abstract

Objective: The study was planned based on the demographic characteristics (age and gender) of 36704 people who applied to a hospital in the Istanbul European region with the suspicion of COVID-19.
Method: Nasopharyngeal and oropharyngeal swab samples were taken from people who applied to the hospital between November 2020 and March 2021, and the detection of the SARS-CoV-2 virus was made by RT-qPCR technique. The data were evaluated with chi-square analysis and SPSS 28 statistical program was used in all calculations. Using the COVID-19 data in the first, middle, and last five days of the specified months, observing the course of the pandemic in this period was desired.
Results: It was found that the most COVID-19 PCR test was performed in November 2020 with 13380 (36.4%) cases and 2347 of the cases were detected as positive. It was observed that 4231 (11.5%) of the total cases (36704) were positive in all of the mentioned months. The highest number of positive cases is between the ages of 20-39 with 1995 people (47.1%). The following 1442 (34.8%) cases were reported to be between the ages of 40-59. While the distribution of COVID-19-positivepatients by age groups in November 2020 did not differ significantly between men and women, significant differences were found in December. The distribution of Covid-19 COVID-19 positive patients by age groups in 2020 and 2021 showed a significant difference. While the proportion of patients aged 0-9, 20-39, and over 60 was higher in 2020, the proportion of patients aged 10-19 and 40-59 was higher in 2021.
Conclusion: The effect of age and gender factors in the pandemic triage of individuals during the pandemic period when they were exposed to the COVID-19 epidemic was investigated retrospectively. No application has been made to harm the private information of the patients. The study is thought to contribute to detecting the SARS-CoV-2 virus, detecting pandemics and epidemics, and managing treatment, especially depending on age and gender.

Keywords

Covid-19, RT-qPCR, SARS-Cov2, viral tanı, pandemi

İSTANBUL’DA BİR HASTANEYE BAŞVURAN KİŞİLERDE YAŞ VE CİNSİYET DEĞİŞKENLERİNİN SARSCOV-2 ÜZERİNE ETKİSİNİN ARAŞTIRILMASI

Abstract

References

• Işsever H, Işsever T, Oztan G. COVID-19 Epidemiyolojisi. Istanbul University Institute of Health Sciences. Journal of Research Health Science. 2020; 3(Ek Sayı 1): 2-13.
• Zaman Kaya F. A View of Smoking from the Covid-19 Perspective. Klinik Tıp Aile Hekimliği J. 2020; 12(2): 48-53.
• Intikam A, Midzi H, Kasambala M, Mutandadzi H, Mduluza-Jokonya T, L Rusakaniko S et al. A systematic and meta-analysis review on the diagnostic accuracy of antibodies in the serological diagnosis of COVID-19. Systematic Reviews. 2021; 10:2-23.
• Karataş Z. Social Impacts of COVID-19 Pandemic, Change and Empowerment. TUSHAD 2020; 4(1): 3-15.
• Amin J, Anjum M A, Sharif M, Saba T, Tariq U. An intelligence design for detection and classification of COVID19 using fusion of classical and convolutional neural network and improved microscopic features selection approach. Microscopy Research and Technique. 2021; 84(10):2254-2267.
• Tokgün P, Dedeoğlu S, Tomatır A. Molecular biology and genetic studies in combating the new coronavirus (Covid-19) outbreak. J of Advanced Research in Health Sci. 2022; 5(1): 41-49.
• Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M, et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020; 369, 77-81.
• Durmaz B. Microbiological Diagnosis in COVID-19 Infection. Journal of Health Science Yuksek Ihtisas University 2020; 1: 12-17.
• Şengöz G. COVID-19: Tarihten Alınacak Dersler var mı In: Çakmakoğlu, S Sırma Ekmekçi, U C, Küçüksezer V, Yılmaz G Deniz. eds. Covid-19: Moleküler ve Kli̇ni̇k Yaklaşım. İstanbul: İstanbul Üniversitesi Yayınevi. 2020: 3-9.
• Altın Z. Elderly People in Covid-19 Outbreak. The journal of Tepecik Education and Research Hospital. 2020; 30: 49-57.
• Hotar N, Omay R E, Bayrak S, Kuruüzüm Z, Ünal B. Social Reflections of the Pandemic. İzmir Journal of Economics 2020; 35(2): 211-220.
• Güldaval F, Anar C, Gayaf M, Büyükşirin M, Polat G, Karadeniz G et al. ark. Clinical presentation of health care workers with symptoms of coronavirus disease 2019 at the İzmir tertiary education hospital, during an early phase of the pandemic. Tuberk Toraks. 2020; 68(3):218-226.
• Bhuiyan M U, Stiboy E, Hassan M Z, Chan M, Islam M S, Haider N et al. Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis. Vaccine. 2021; 39(4):667-677.
• Jiang Z, Sun J, Li X, Lyu Y. Characteristics and Outcome of 69 Cases of Coronavirus Disease 2019 (COVID-19) in Lu’an City, China Between January and February 2020. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 2020; 14-26:e925442.
• Dong Y, Mo X, Hu Y, Q X, Jiang F, Jiang Z et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020; 145(6): 2-10.
• Wang D, Yin Y, Hu C, Liu X. Zhang X, Zhou S et al. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. Critical Care. 2020; 24(188): 2-9.
• Wei Y, Zeng W, Huang X, Li J, Qiu X, Li H et al. Clinical characteristics of 276 hospitalized patients with coronavirus disease 2019 in Zengdu District, Hubei Province: A single-center descriptive study. BMC Infectious Diseases. 2020; 20(1): 2-10
• Bhatraju P K, Ghassemieh B J, Nichols M, Kim R, Jerome K R, Nalla A K et al. Covid-19 in Critically Ill Patients in the Seattle Region—Case Series. The New England Journal of Medicine. 2020; 382(21): 1-11.
• Farghaly S, Badedi M, Ibrahim R, Sadhan M H, Alamoudi A, Alnami A et al. A clinical characteristics and outcomes of post-COVID-19 pulmonary fibrosis. Medicine. 2022; 101(3), 1-7.
• Toba N, Gupta S, Ali A Y, ElSaban M, Khamis A H, Ho S B et al. COVID-19 under 19: A meta-analysis. Pediatric Pulmonology. 2021; 56(6): 1332-1341.
• Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y et al. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet (London, England). 2021; 398(10302): 747-758.
• Chen X, Li Y, Shao T R, Yang L L, Li S J, Wang X J, Cen Y. Some characteristics of clinical sequelae of COVID-19 survivors from Wuhan, China: A multi-center longitudinal study. Influenza and Other Respiratory Viruses. 2022; 16(3): 395-401.
• Cilli A, Hanta I, Uzer F, Coskun F, Sevinc C, Deniz P P et al. A. Characteristics and outcomes of COVID-19 patients with IPF: A multi-center retrospective study. Respiratory Medicine and Research. 2022; 81: 1-4.
• Koupaei M, Mohamadi M H, Yashmi I, Shahabi A H, Shabani A H, Heidary M et al. Clinical manifestations, treatment options, and comorbidities in COVID‐19 relapse patients: A systematic review. Journal of Clinical Laboratory Analysis. 2022; 36(5): 1-20.